The US Food and Drug Administration could authorize COVID-19 boosters from Pfizer Inc and BioNTech SE for use in 16- and 17-year olds as soon as next week, the Wall Street Journal reported late on Monday, citing a person familiar with the planning.
FDA moving to authorize Pfizer booster for 16-, 17-year-olds - report
By REUTERS
11/24/2024 09:11 PM
By REUTERS
11/24/2024 06:51 PM
By REUTERS
11/24/2024 05:13 PM
By REUTERS
11/24/2024 03:21 PM
By REUTERS
11/24/2024 01:09 PM
By REUTERS
11/24/2024 12:29 PM
By REUTERS
11/24/2024 12:27 PM